<DOC>
	<DOC>NCT00245973</DOC>
	<brief_summary>The purpose of the study is to investigate whether eight weeks of treatment with flexible doses of Bifeprunox is superior to treatment with placebo in depressed patients with bipolar disorder.</brief_summary>
	<brief_title>Study Evaluating Bifeprunox in Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Men and women 18 to 65 years of age, inclusive. Diagnosis of Bipolar Disorder and must be experiencing a depressive episode. This is a follow on study to protocol 3168A2304. Only subjects who have participated in the previous study are eligible.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>